1. Acknowledgement to Referees

   Acknowledgement to Referees Open access 08 November 2023 Pages: 297 - 299

2. Tremor Induced by Cyclosporine, Tacrolimus, Sirolimus, or Everolimus: A Review of the Literature

   • Aparna Wagle Shukla
   • Caroline Lunny
   • Ashutosh M. Shukla

   Review Article Open access 22 August 2023 Pages: 301 - 329

   

3. The Benefits and Risks of Switching from Fingolimod to Siponimod for the Treatment of Relapsing–Remitting and Secondary Progressive Multiple Sclerosis

   • Martin Vališ
   • Anat Achiron
   • Zbyšek Pavelek

   Review Article Open access 28 August 2023 Pages: 331 - 338

   

4. A Guide to Expanding the Use of Buprenorphine Beyond Standard Initiations for Opioid Use Disorder

   • James C. Miller
   • Michael A. Brooks
   • John F. Wurzel III

   Review Article Open access 08 November 2023 Pages: 339 - 362

   

5. In-Use Stability of SB12 (Eculizumab, Soliris Biosimilar) Diluted in Saline and Dextrose Infusion Solution after an Extended Storage Period

   • Minji Tak
   • Hawon Jeong
   • Su Jin Park

   Original Research Article Open access 22 August 2023 Pages: 363 - 375

   

6. Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab

   • Yijia Jiang
   • Taruna Arora
   • Karen J. Miller

   Original Research Article Open access 26 August 2023 Pages: 377 - 395

   

7. Looking into the Kinetics of NT-proBNP and sST2 Changes in Patients with Heart Failure Treated with Sacubitril/Valsartan: A Hint to Different Therapeutic Pathways

   • Massimo Mapelli
   • Irene Mattavelli
   • Piergiuseppe Agostoni

   Original Research Article Open access 13 September 2023 Pages: 397 - 402

   

8. Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System

   • Dehua Zhao
   • Xiaoqing Long
   • Jisheng Wang

   Original Research Article Open access 12 September 2023 Pages: 403 - 409

9. Effect of Tucatinib on Cardiac Repolarization in Healthy Volunteers

   • Ariel R. Topletz-Erickson
   • JoAl G. Mayor
   • Christopher J. Endres

   Original Research Article Open access 26 September 2023 Pages: 411 - 419

   

10. Analytical and Functional Similarity of the Biosimilar Candidate ABP 654 to Ustekinumab Reference Product

    • Greg Cantin
    • Qian Liu
    • Jennifer Liu

    Original Research Article Open access 13 October 2023 Pages: 421 - 438

    

11. Simvastatin Preferentially Targets FLT3/ITD Acute Myeloid Leukemia by Inhibiting MEK/ERK and p38-MAPK Signaling Pathways

    • Genhong Li
    • Jingwei Yao
    • Bing Xu

    Original Research Article Open access 17 October 2023 Pages: 439 - 451

    

12. Human Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC42, a Novel Farnesoid X Receptor Agonist

    • Handan He
    • Jinzi J. Wu

    Original Research Article Open access 02 November 2023 Pages: 453 - 464

    

13. Effect of High-Fat Food on the Pharmacokinetic Profile and Safety of SAF-189s, an ALK/ROS1 Inhibitor, in Healthy Chinese Adults

    • Huiling Qin
    • Yan Tan
    • Wei Hu

    Original Research Article Open access 07 November 2023 Pages: 465 - 473